Shreehas Tambe, takes on the role of Deputy CEO of Biocon Biologics, wef March 1, 2021. Tambe has been with Biocon since 1997 and has played  a critical role in shaping the biosimilars business, till most recently he was the Chief Operating Officer of Biocon Biologics. 

He has over 20 years of leadership experience in operational and strategic roles and has led large, diverse teams at R&D, manufacturing and projects & engineering during his tenure.

Previously, as the Senior Vice President & Global Head of Biocon’s insulins business unit he was responsible for the P&L and expanding the insulins portfolio across several geographies.

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Biologics, said: “I am delighted to welcome Shreehas Tambe in his new role as the Deputy CEO of Biocon Biologics. Shreehas has also worked closely with Dr Arun Chandavarkar, Managing Director of Biocon Biologics, on formulating business strategies and achieving operational excellence.”

Dr Arun Chandavarkar, Managing Director, Biocon Biologics said: “I would like to congratulate Shreehas Tambe for his new role as the Deputy CEO of Biocon Biologics. Shreehas has played a critical role in shaping our biosimilars business over the years in different roles and more recently as the COO of Biocon Biologics.”

Tambe said, “I am deeply honoured to take on this role to drive Biocon Biologics towards becoming a global leader in affordable healthcare. Along with the leadership team, I am looking forward to realising the several opportunities that lie ahead of us and work collaboratively to address challenges.”

Tambe holds a Masters’ degree in Bioprocess Technology from ICT (UDCT), University of Mumbai and has also studied Pharmaceutical Sciences & Technology at University of Pune. He was conferred the coveted Distinguished Alumnus Award (Professional) by his alma mater, the prestigious ICT, Mumbai, in 2020.